Magnesium Sulfate in Water for Injection, USP, 4g/100mL, IV bag
Product details
- Magnesium Sulfate in Water for Injection, USP, 4g/100mL, IV bag
Company announcement
Amneal Pharmaceuticals is recalling one lot of Magnesium Sulfate in Water for Injection due to a product mix-up.
A pouch labeled as Magnesium Sulfate was found to contain an IV bag of Tranexamic Acid.
The affected lot (AH250162) was distributed nationwide to wholesalers/distributors between December 22, 2025, and February 27, 2026.
There have been no adverse event reports related to this recall.
Risk:
There is a reasonable probability that delay in receiving magnesium therapy could result in life-threatening or long-term morbidity in pregnant individuals with preeclampsia or eclampsia due to the potential to develop seizures. Additionally, delay in receiving magnesium therapy in preterm pregnant individuals could result in long-term morbidity for the preterm neonate due to complications of prematurity. If Tranexamic Acid (TXA) is inadvertently administered it could result in adverse events, including blood clotting, seizures, hypersensitivity reactions, visual disturbances, and dizziness.
Impacted states: Nationwide
Products:
- Magnesium Sulfate in Water for Injection, USP, 4g/100mL, IV bag (UPC code(s): 7012117203)
Contact
For more information, call 833-582-0812 or email MagnesiumSulfateRecall@amneal.com.